SCHEMBL3390107

SCHEMBL3390107

C=C(C(=O)OC)C12CC1CC(C(C)=O)(C(=O)OCC)C2

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1394904 0.93 LMNA (0.35) LMNA
SCHEMBL14019700 0.91 LMNA (0.33) LMNA
SCHEMBL13008563 0.86 ALDH1A1 (0.35)
SCHEMBL13108985 0.83 EPHX1 (0.32)
SCHEMBL13108984 0.82
SCHEMBL13108999 0.82 LMNA (0.31) LMNA
SCHEMBL14019698 0.81 ADAM17 (0.39)
SCHEMBL13001800 0.81 ALDH1A1 (0.31)
SCHEMBL13108974 0.81 POLB (0.32) LMNA
SCHEMBL4609091 0.80 POLB (0.32) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11135136-B2 Dental materials based on urethane-group-containing vinylcyclopropane derivatives IVOCLAR VIVADENT AG (LI) 2021-10-05 US disclosed
US-10660825-B2 2020-05-26 US disclosed
US-20190167533-A1 DENTAL MATERIALS BASED ON URETHANE-GROUP-CONTAINING VINYLCYCLOPROPANE DERIVATIVES IVOCLAR VIVADENT AG (LI) 2019-06-06 US disclosed
US-20180036209-A1 Dental Materials Based on Monofunctional Vinylcyclopropane Derivatives IVOCLAR VIVADENT AG (LI) 2018-02-08 US disclosed
EP-1688125-B1 Composition comprising polymerisable cyclopropylacrylates IVOCLAR VIVADENT AG (LI) 2010-12-29 EP disclosed
EP-1688125-B1 Composition comprising polymerisable cyclopropylacrylates IVOCLAR VIVADENT AG (LI) 2010-12-29 EP disclosed
US-7816476-B2 Polymerizable cyclopropyl acrylates IVOCLAR VIVADENT AG (LI) 2010-10-19 US disclosed
US-7816476-B2 Polymerizable cyclopropyl acrylates IVOCLAR VIVADENT AG (LI) 2010-10-19 US disclosed
EP-1688125-A1 Polymerisable cyclopropylacrylates Ivoclar Vivadent AG (LI) 2006-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180036209-A1 Dental Materials Based on Monofunctional Vinylcyclopropane Derivatives HVCN1, RAD51, HYOU1 LMNA 770/4885
US-20190167533-A1 DENTAL MATERIALS BASED ON URETHANE-GROUP-CONTAINING VINYLCYCLOPROPANE DERIVATIVES RAD51, CBR1, DECR1 LMNA 1045/4885
US-11135136-B2 Dental materials based on urethane-group-containing vinylcyclopropane derivatives RAD51, CBR1, DECR1 LMNA 1045/4885
US-10660825-B2 OXER1, CBR1, RAD51 LMNA 468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.